Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect"

J Glob Antimicrob Resist. 2020 Dec:23:290-291. doi: 10.1016/j.jgar.2020.10.004. Epub 2020 Oct 29.

Abstract

  1. •

    COVID-19 patients have an exaggerated risk of acquiring BSI during ICU stay.

  2. •

    The incidence of ICU-acquired BSI in COVID-19 patients is higher than that reported in European ICUs in the pre-COVID-19 period.

  3. •

    The commonest aetiological agents of BSI were intestinal commensals.

  4. •

    A high rate of acquisition of VRE colonisation was observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bacteremia / blood
  • Bacteremia / epidemiology*
  • Bacteremia / virology
  • Bacteria / isolation & purification
  • COVID-19 / blood
  • COVID-19 / epidemiology
  • COVID-19 / microbiology*
  • Cohort Studies
  • Coinfection / blood
  • Coinfection / microbiology
  • Critical Care / statistics & numerical data
  • Female
  • Fungemia / blood
  • Fungemia / epidemiology*
  • Fungemia / virology
  • Fungi / isolation & purification
  • Humans
  • Incidence
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Mortality
  • Retrospective Studies
  • SARS-CoV-2 / isolation & purification